Search clinical trials for: Pertuzumab trastuzumab
Total 1383 results
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Hoffmann-La RocheCompletedBreast CancerSpain, United States, France, Germany, Belgium, Korea, Republic of, Italy, Russian Federation
-
Guangdong Provincial People's HospitalUnknown
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island HospitalActive, not recruitingAcute Myeloid LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Asan Medical CenterRecruitingGastric or Gastroesophageal Junction(GEJ) AdenocarcinomaKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
Shanghai Miracogen Inc.RecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Cancer Trials IrelandCompleted
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerTaiwan, Korea, Republic of, Thailand, Malaysia
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKlineCompletedBreast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Boehringer IngelheimRecruitingMetastatic Breast Cancer | Esophageal Adenocarcinoma | Metastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Hong Kong, United States, Canada, Mexico, Denmark, Germany, Portugal, Taiwan, Switzerland, Bulgaria, Korea, Republic of, Singapore, United Kingdom, Slovenia, Bosnia and Herzegovina, Russian Federation, Br... and more
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
AstraZenecaDaiichi SankyoNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
Institut für Klinische Krebsforschung IKF GmbH...Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...RecruitingBiliary Tract Cancer | HER2 Gene MutationGermany
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Incyte CorporationTerminated
-
Boehringer IngelheimCompletedStomach Neoplasms | Breast NeoplasmsFrance
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid LeukemiaItaly
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Versailles HospitalCompletedAcute Myeloid LeukemiaFrance
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Fudan UniversityNot yet recruiting
-
Dorte NielsenCompletedMetastatic Breast Cancer | Liver MetastasesDenmark
-
Dorte NielsenCompletedMetastatic Breast Cancer | Liver MetastasesDenmark
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminated
-
Fox Chase Cancer CenterNational Comprehensive Cancer Network; Puma Biotechnology, Inc.RecruitingGastric CancerUnited States
-
xuexin heRecruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Base Therapeutics (Shanghai) Co., Ltd.Shanghai 10th People's HospitalEnrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States